Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Pudendal Nerve Block for Pain Relief During Episiotomy Repair

14 november 2026 uppdaterad av: Zeenat Usman, Shaheed Zulfiqar Ali Bhutto Medical University

Pudendal Nerve Block for Pain Relief During Episiotomy Repair: A Randomized Controlled Trial

Episiotomy is a surgical cut made in the perineum, the area between the vagina and anus, during vaginal childbirth. Repairing an episiotomy can cause pain, and adequate pain relief is important for maternal comfort during and after delivery.

This study will compare two methods of providing anesthesia during episiotomy repair in women undergoing vaginal delivery with a mediolateral episiotomy at the Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.

A total of 80 eligible women will be enrolled and randomly assigned in equal numbers to two groups. The intervention group will receive a bilateral pudendal nerve block in addition to routine episiotomy repair and standard postpartum pain relief. The control group will receive conventional local anesthetic infiltration around the episiotomy area, along with routine repair and standard postpartum pain relief.

Pain will be assessed using a 100-mm Visual Analogue Scale (VAS), on which 0 represents no pain and 100 represents the worst imaginable pain. Pain will be assessed during episiotomy repair and at 1, 3, and 6 hours after delivery.

The study will also compare the need for additional pain medication, pain during sitting and walking, patient comfort and satisfaction, the duration of episiotomy repair, the need for additional local anesthetic, and complications associated with the procedures.

The aim is to determine whether pudendal nerve block provides better pain relief during episiotomy repair and improves early postpartum comfort compared with conventional local anesthetic infiltration.

Studieöversikt

Detaljerad beskrivning

Episiotomy is a surgical incision of the perineum performed during vaginal delivery and may be associated with pain during repair and in the early postpartum period. Conventional local perineal infiltration is commonly used to provide anesthesia during episiotomy repair; however, adequate pain relief may not always be achieved.

The pudendal nerve supplies sensory innervation to the vulva, lower vagina, perineum, and anus. Pudendal nerve block is a regional anesthetic technique that may provide effective analgesia during episiotomy repair. This study will evaluate the effectiveness of pudendal nerve block compared with conventional local perineal infiltration in women undergoing mediolateral episiotomy at the Department of Maternal and Child Health, Pakistan Institute of Medical Sciences (MCH PIMS), Islamabad.

Eligible women aged 18 years or older who undergo vaginal delivery with mediolateral episiotomy will be recruited after eligibility assessment and informed consent. Participants will be randomly allocated to one of two groups. The intervention group will receive bilateral pudendal nerve block using 2% lidocaine, in addition to routine episiotomy repair and standard postpartum analgesia. The control group will receive conventional local perineal infiltration according to the institutional protocol. Both groups will receive routine episiotomy repair and standard postpartum analgesia.

Pain intensity will be assessed using a 100-mm Visual Analogue Scale during episiotomy repair and at 1, 3, and 6 hours postpartum. Additional assessments will include the need for rescue analgesia, pain during sitting and walking, patient-reported comfort and satisfaction, duration of repair, requirement for additional local anesthetic, and the success or failure of the nerve block. Adverse events and complications associated with the procedures will also be documented.

The study aims to determine whether pudendal nerve block improves pain relief during episiotomy repair and early postpartum comfort compared with conventional local perineal infiltration. The findings may contribute to the local evidence base for pain management during episiotomy repair.

Studietyp

Interventionell

Inskrivning (Beräknad)

80

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Zeenat Usman/Medical officier, MS obstetrics and gyanecology
  • Telefonnummer: +923315333910
  • E-post: usmanbut2@gmail.com

Studera Kontakt Backup

  • Namn: Sobia Luqman/Assisstant Professor, FCPS obstetrics and gyane
  • Telefonnummer: +923348626904
  • E-post: sobialuqman8@gmail.com

Studieorter

    • ICT
      • Islamabad, ICT, Pakistan, 04485
        • Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS)
        • Kontakt:
          • Zeenat Usman, MS obstetrics and Gyanecology
          • Telefonnummer: +923315333910
          • E-post: usmanbut2@gmail.com
        • Kontakt:
        • Huvudutredare:
          • Zeenat Usman, Ms Obsterics and gyanecology
        • Underutredare:
          • Sobia Luqman, FCPS-obstertics and gyanecolog
        • Underutredare:
          • Lubaba Tahir

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 50 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Kvinna

Beskrivning

Inclusion Criteria:

  • Women aged 18 years or older
  • Singleton pregnancy
  • Vaginal delivery at MCH PIMS
  • Requirement for mediolateral episiotomy
  • Clinically uncomplicated episiotomy requiring routine repair
  • Ability to understand the study information and provide written informed consent

Exclusion Criteria:

  • Allergy or contraindication to the proposed local anesthetic
  • Known coagulation disorder or significant bleeding tendency
  • Local infection at the proposed injection site
  • Associated third- or fourth-degree perineal tear
  • Extensive vaginal or cervical laceration requiring additional anesthesia
  • Major postpartum hemorrhage or another major postpartum complication requiring urgent management
  • Chronic pelvic or perineal pain, or regular use of analgesic medication before delivery
  • Inability to understand the pain assessment scale or provide informed consent
  • Failed pudendal nerve block despite appropriate technique

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Pudendal Nerve Block Group

Participants will receive bilateral pudendal nerve block using 2% lidocaine, 2 mL, as specified in the study protocol. The procedure will be performed by an appropriately trained obstetrician or anesthetist using a standardized technique. Routine episiotomy repair and standard postpartum analgesia will also be provided.

Bilateral pudendal nerve block performed using the standardized technique specified in the study protocol, with the local anesthetic described in the protocol (2% lidocaine, 2 mL). The procedure will be performed by an appropriately trained obstetrician or anesthetist, in addition to routine episiotomy repair and standard postpartum analgesia.

Local anesthetic administered for bilateral pudendal nerve block at a dose of 2 mL, as specified in the study protocol.

Aktiv komparator: Conventional Local Infiltration Group

Participants will receive conventional local perineal infiltration anesthesia according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will be provided.

Conventional local anesthetic infiltration around the episiotomy site according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will also be provided.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Pain intensity during episiotomy repair
Tidsram: During episiotomy repair

Pain intensity will be measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 mm represents the worst imaginable pain. Pain will be assessed at predefined stages during episiotomy repair, including after anesthesia administration, at commencement of repair, during repair, and at completion of repair.

During episiotomy repair

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Postpartum pain intensity
Tidsram: 1, 3, and 6 hours postpartum

pain intensity measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 represents the worst imaginable pain.

1, 3, and 6 hours postpartum
Requirement for rescue analgesia
Tidsram: First 6 hours postpartum

Proportion of participants requiring additional analgesic medication for inadequate episiotomy-related pain relief.

First 6 hours postpartum
Patient satisfaction with pain management
Tidsram: 1-6 hours postpartum

Patient satisfaction with pain management assessed using a 5-point Likert scale, ranging from very dissatisfied to very satisfied.

1-6 hours postpartum

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

31 oktober 2026

Primärt slutförande (Beräknad)

31 januari 2027

Avslutad studie (Beräknad)

15 februari 2027

Studieregistreringsdatum

Först inskickad

13 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

13 oktober 2026

Första postat (Faktisk)

20 oktober 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

14 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

De-identified individual participant data collected during this study will not be shared with researchers outside the study team. Study data will be used for the planned analyses and reporting of study findings.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera